Download Files:
Products Details
Product Description
– CTA056 is an ITK (IL-2-inducible T-cell kinase) inhibitor with an IC50 of 0.1 μM. CTA056 selectively targets malignant T cells and modulates oncomirs. CTA056 induces apoptosis and is a potential therapeutic agent for the research of T-cell leukemia and lymphoma[1].
Web ID
– HY-110113
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C35H34N6O
References
– [1]Guo W, et al. Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs. Mol Pharmacol. 2012 Nov;82(5):938-47.
CAS Number
– 1265822-30-7
Molecular Weight
– 554.68
SMILES
– O=C1C(CC2=CC=CC=C2)=NC3=C(N1)C=C(N=C4C5=CC=C(C6=CC=NC=C6)C=C5)C(N4CCCN7CCCCC7)=C3
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Btk
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation.
